Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial
      QxMD      Google Scholar   
Citation:
J. Clin. Oncol vol 37 (26) 2338-2348
Year:
2019
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Long-Term-Followup
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
9
Parents:
2300  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Roche  
Grants:
U10CA180821, U10CA180882, UG1CA189823, U10CA180790, U10CA180857, U10CA180867, P30CA033572; U10CA180820, U10CA180802 (ECOG-ACRIN); U10CA180888 (SWOG); U10CA180863 (CCTG)  
Corr. Author:
 
Authors:
                                                         
Networks:
AURORA, CA249, LAPS-CT018, LAPS-IL036, LAPS-MA036, LAPS-MD017, LAPS-MN026, LAPS-NC007, LAPS-NC010, LAPS-NY016, MAINE, PR028, SCOR   
Study
CALGB-49907
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
ORIGINAL REPORTS, Breast Cancer